Chikungunya Vaccine Backed by European Medicines Agency
The European Medicines Agency (EMA) has recommended granting a marketing authorization in the European Union for Ixchiq (Valneva Austria), the first vaccine for EU countries intended to protect adults aged 18 years or older against chikungunya. Chikungunya …